Nigeria launches twice-yearly HIV prevention injection Lenacapavir: Video
Nigeria has officially introduced Lenacapavir, a groundbreaking twice-yearly injection set to transform the country’s HIV prevention strategy by replacing daily oral medication with a more convenient bi-annual regimen.
At a launch event in Abuja themed “Flagging off the future of HIV prevention,” the first recipients were administered the long-acting dose, marking a significant milestone in the country’s fight against HIV/AIDS.
Speaking at the event, Adedolapo Fasawe, Mandate Secretary for Health and Environment in the Federal Capital Territory, explained that the drug is strictly for prevention.
“Lenacapavir is long-acting and is for the prevention of HIV/AIDS,” she said, stressing the importance of testing negative before receiving the injection. “If you're positive, the medicine doesn't work… and may even be injurious to your health.”
This story is written and edited by the Global South World team, you can contact us here.
